Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sevoflurane + desflurane is a combination of two volatile inhalational anesthetics, both widely used for the induction and maintenance of general anesthesia in adults and pediatric patients. Both agents are nonflammable, highly fluorinated ethers with rapid onset and offset properties, making them suitable for outpatient procedures and situations requiring quick emergence from anesthesia. Their mechanism of action involves modulation of multiple ligand-gated ion channels in the central nervous system—primarily enhancing inhibitory neurotransmission via GABA(A) receptors and glycine receptors while inhibiting excitatory neurotransmission through antagonism at glutamate (NMDA) receptors, among others. Both drugs also affect various ionic currents including calcium, potassium, and sodium channels. Sevoflurane is known for its smooth induction profile with minimal airway irritation; desflurane offers even faster recovery but can cause airway irritation at higher concentrations. The combination may be considered experimentally or in research settings to compare or optimize anesthetic effects but is not a standard marketed fixed-dose product[1][2][4][5][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sevoflurane + desflurane.